Retinal Degeneration 3 (RD3) (N-Term) Peptide
Aperçu rapide pour Retinal Degeneration 3 (RD3) (N-Term) Peptide (ABIN8110359)
Antigène
Source
Application
-
-
Protein Region
- N-Term
-
Fonction
- RD3 Peptide - N-terminal region
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-RD3 antibody ( ARP55856_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- RD3 (Retinal Degeneration 3 (RD3))
-
Sujet
-
Background Information: RD3 is preferentially expressed in retina.Defects in RD3 are the cause of Leber congenital amaurosis type 12 (LCA12).
Alternative Symbols: C1orf36, LCA12
-
Poids moléculaire
- 23kDa
-
ID gène
- 343035
-
NCBI Accession
- NP_898882
-
UniProt
- Q7Z3Z2
Antigène
-